5 thoughts on “Max Levchin talks about data, sensors and the plan for his new startup(s)”

  1. Wasn’t Slide a big flop – raising a ton of VC money, never finding an audience or business model, and finally bailing out to Google, which shut it down? Might have lined the founder’s pockets, but huge amount of money was invested for no return.

    1. @Sbpots –

      Yes, Slide was a big flop. However, they were able to put up a “dog and pony” show in front of Google and cash out.


  2. Om, nice article. I appreciated reading especially the human element of Max and how he has changed his view about the cycle (4-year v.s. longer term) as he has aged and become wiser. This is very refreshing especially for those in Silicon Valley which seems to stress youth and the next Harvard or Stanford drop out. Also, what made me smile when reading this article is that Max has this longer-term view now, and while he seems to feel its new (compared to the 4-year cycle), one can look at the late Steve Jobs who held the longer term view most of his life as well. Good luck Max!

  3. Om, thanks for including AdRoll in today’s your article. However, we don’t consider ourselves to have “briefly flirted with bright lights.” On the contrary, we were named the fastest-growing privacy advertising company by Inc. Magazine in their 2012 Inc. 500|5000 listing and the fastest growing private company in the Bay Area this past year by the SF Business Times.

    We’re super excited about the future of retargeting, especially Facebook Exchange, and would love to share our 2012 growth and plans for 2013 with you at any time (press@adroll.com).

  4. Medicine is pretty broken these days, but there are several hot prospects that present themselves. One example is to apply a fraction of a megabuck to do a serious clinical trial to any of several hot supplements that are too small to afford it on their own. Finding a way past or through the FDA is a political issue, but popularity is an asset. See Aubrey de Grey’s “Ending Aging” for a great overview of an incredible marketing opportunity.

    Another would be to cure virtually all cancers by screening for early signs and using known but forbidden cures and watching them work by tracking nagalase levels using a test rather like the incredible screening test invented by the 14 year old Jack Andraka. It will appeal to some because of the vital use of carbon nanotubes. Let’s talk about it.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.